Your shopping cart is currently empty

FGFR-IN-24 (Compound 8r) is an inhibitor of FGFR with potent activity against FGFR1/2/3, exhibiting IC50 values of 10.0, 6.9, and 30.2 nM, respectively. It also demonstrates strong inhibitory effects on mutant forms FGFR1V561M, FGFR2V564F, and FGFR2N549K, with IC50 values of 6.8, 0.7, and 0.8 nM. FGFR-IN-24 induces apoptosis (Apoptosis) and effectively inhibits the phosphorylation of FGFR2 and its downstream signaling mediators (AKT and MAPK). It shows promising anti-tumor efficacy in the RT112/84 bladder cancer xenograft model.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | FGFR-IN-24 (Compound 8r) is an inhibitor of FGFR with potent activity against FGFR1/2/3, exhibiting IC50 values of 10.0, 6.9, and 30.2 nM, respectively. It also demonstrates strong inhibitory effects on mutant forms FGFR1V561M, FGFR2V564F, and FGFR2N549K, with IC50 values of 6.8, 0.7, and 0.8 nM. FGFR-IN-24 induces apoptosis (Apoptosis) and effectively inhibits the phosphorylation of FGFR2 and its downstream signaling mediators (AKT and MAPK). It shows promising anti-tumor efficacy in the RT112/84 bladder cancer xenograft model. |
| Targets&IC50 | FGFR1:10.0 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.